Treace Medical Concepts, Inc.
TMCI · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $50,214 | $47,387 | $52,570 | $68,708 |
| % Growth | 6% | -9.9% | -23.5% | – |
| Cost of Goods Sold | $10,508 | $9,635 | $10,677 | $13,231 |
| Gross Profit | $39,706 | $37,752 | $41,893 | $55,477 |
| % Margin | 79.1% | 79.7% | 79.7% | 80.7% |
| R&D Expenses | $4,680 | $5,498 | $5,562 | $5,210 |
| G&A Expenses | $16,281 | $16,144 | $15,791 | $13,612 |
| SG&A Expenses | $49,702 | $49,228 | $51,913 | $50,471 |
| Sales & Mktg Exp. | $33,421 | $33,084 | $36,122 | $36,859 |
| Other Operating Expenses | $1,000 | $0 | $0 | $0 |
| Operating Expenses | $55,382 | $54,726 | $57,475 | $55,681 |
| Operating Income | -$15,676 | -$16,974 | -$15,582 | -$204 |
| % Margin | -31.2% | -35.8% | -29.6% | -0.3% |
| Other Income/Exp. Net | -$612 | -$424 | -$340 | -$297 |
| Pre-Tax Income | -$16,288 | -$17,398 | -$15,922 | -$501 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$16,288 | -$17,398 | -$15,922 | -$501 |
| % Margin | -32.4% | -36.7% | -30.3% | -0.7% |
| EPS | -0.26 | -0.28 | -0.25 | -0.008 |
| % Growth | 7.1% | -12% | -3,025% | – |
| EPS Diluted | -0.26 | -0.28 | -0.25 | -0.008 |
| Weighted Avg Shares Out | 63,515 | 63,007 | 62,661 | 62,341 |
| Weighted Avg Shares Out Dil | 63,515 | 63,007 | 62,661 | 62,341 |
| Supplemental Information | – | – | – | – |
| Interest Income | $634 | $775 | $841 | $899 |
| Interest Expense | $1,338 | $1,321 | $1,311 | $1,314 |
| Depreciation & Amortization | $2,778 | $2,576 | $2,461 | $2,237 |
| EBITDA | -$12,172 | -$13,501 | -$12,150 | $3,050 |
| % Margin | -24.2% | -28.5% | -23.1% | 4.4% |